SCHEMBL12349141

SCHEMBL12349141

[O-]/[N+](=C\c1ccc(/C=[N+](\[O-])c2ccc(Br)cc2)cc1)c1ccc(Br)cc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ G6PD P11413 4/20 0.81
▸ ALDH1A1 P00352 8/20 0.75
▸ MAPT P10636 8/20 0.75
▸ NPC1 O15118 5/20 0.75
▸ RAB9A P51151 4/20 0.75
▸ HSD17B10 Q99714 2/20 0.75
▸ HPGD P15428 1/20 0.75
▸ MAPK1 P28482 1/20 0.61
▸ SMN1; SMN2 Q16637 1/20 0.61
▸ NPSR1 Q6W5P4 1/20 0.61
▸ ALOX15 P16050 2/20 0.52
▸ TSHR P16473 1/20 0.52
▸ RECQL P46063 1/20 0.52
▸ GAA P10253 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ CYP2A6 P11509 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ HSP90AA1 P07900 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11403099 0.90 ALDH1A1 (0.69) G6PDALDH1A1MAPTNPC1RAB9A
SCHEMBL2242956 0.90 G6PD (1.00) G6PDALDH1A1MAPTNPC1RAB9A
SCHEMBL28618274 0.90 G6PD (0.85) G6PDALDH1A1MAPTNPC1RAB9A
SCHEMBL12355277 0.90 G6PD (1.00) G6PDALDH1A1MAPTNPC1RAB9A
SCHEMBL11413895 0.90 G6PD (0.85) G6PDALDH1A1MAPTNPC1RAB9A
SCHEMBL11414227 0.77 ALDH1A1 (0.81) G6PDALDH1A1MAPTNPC1RAB9A
SCHEMBL11415098 0.77 ALDH1A1 (0.81) G6PDALDH1A1MAPTNPC1RAB9A
SCHEMBL11404254 0.77 ALDH1A1 (0.53) G6PDALDH1A1MAPTNPC1RAB9A
SCHEMBL11415889 0.77 ALDH1A1 (0.53) G6PDALDH1A1MAPTNPC1RAB9A
SCHEMBL19875637 0.76 ALDH1A1 (0.80) G6PDALDH1A1MAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130071773-A1 HOLOGRAPHIC STORAGE MEDIUM SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2013-03-21 — — US disclosed
US-7989488-B2 Compositions and methods for storing holographic data GENERAL ELECTRIC COMPANY (US) 2011-08-02 — — US disclosed
US-7901839-B2 Compositions and methods for storing holographic data GENERAL ELECTRIC COMPANY (US) 2011-03-08 — — US disclosed
US-20090081560-A1 COMPOSITIONS AND METHODS FOR STORING HOLOGRAPHIC DATA GENERAL ELECTRIC COMPANY (US) 2009-03-26 — — US disclosed
US-20090082580-A1 COMPOSITIONS AND METHODS FOR STORING HOLOGRAPHIC DATA GENERAL ELECTRIC COMPANY (US) 2009-03-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090082580-A1 COMPOSITIONS AND METHODS FOR STORING HOLOGRAPHIC DATA C5, C1S, CYC1 G6PD 4411/4885ALDH1A1 3966/4885MAPT 3093/4885
US-20130071773-A1 HOLOGRAPHIC STORAGE MEDIUM NEFM, NNMT, NOS1 G6PD 489/4885ALDH1A1 1647/4885MAPT 386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback